The Cydan Team
Chris Adams, PhD, MBA
Founder and Chief Executive Officer
Chris Adams brings to Cydan more than 20 years of business development, transactional and commercial planning experience in orphan drug development as well as a successful track record in private and public biotech fund raising.
Prior to joining Cydan, Dr. Adams was President of CMA Biotech Consulting where he worked in an advisory role for a number of development stage orphan drug companies. Previously, Dr. Adams was Chief Business Officer of FoldRx Pharmaceuticals Inc., where he was responsible for business strategy, licensing and business development. He led the M&A process, which resulted in the acquisition of the company by Pfizer in October of 2010. Prior to FoldRx, Dr. Adams was Senior Vice President, Business Development for ViaCell Inc., and Vice President, Business Development for Transkaryotic Therapies Inc. Previously, Dr. Adams served Director of Business Development for the Pharmaceutical Division of Ciba-Geigy Limited, Basel, Switzerland.
Dr. Adams has a diploma in organic chemistry and biochemistry and a PhD in organic chemistry from the University of Zurich. Dr. Adams also holds an MBA from INSEAD of Fontainebleau, France.